Hosted on MSN2mon
Lilly reports positive Phase 3 data for Jaypirca in CLL/SLLEli Lilly (NYSE:LLY) reported positive Phase 3 data from its BRUIN CLL-321 study of its drug pirtobrutunib ... also known as BR, according to a statement. Lilly (LLY) said the updated results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback